Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO
Jan 12, 2022 15:00 HKT |  |
|
Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance
Jan 12, 2022 10:26 HKT | |
|
SinoMab Awarded the "Best Small and Mid-Cap Company" and "Best CEO" in the Selection of the "6th Hong Kong Golden Stocks Awards" and the "Listed Company with the Most Growth Potential" in the Selection of "2021 Sina Finance Golden Unicorn Best Hong Kong and US Listed Companies"
Jan 11, 2022 16:55 HKT |  |
|
Clinical Evaluation of LeSoleil Against COVID-19
Jan 11, 2022 12:00 HKT |  |
|
EC Healthcare expects to achieve a record-high sales volume in third quarter of FY22, Represents more than 40% Y-o-Y increase
Jan 10, 2022 08:18 HKT |  |
|
B-cell lymphoma clinical trials now open on the TrialWire Platform
Jan 05, 2022 17:10 HKT |  |
|
Autism clinical trials now open on the TrialWire Platform
Jan 05, 2022 17:00 HKT | |
|
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
Jan 05, 2022 15:27 HKT |  |
|
Sirnaomics Ltd., RNA Therapeutics Biopharmaceutical Company with Presence in China and US, Lists on Main Board of SEHK
Dec 30, 2021 15:55 HKT | |
|
Sirnaomics Ltd. Announces Proposed Listing on the Main Board of SEHK
Dec 19, 2021 20:48 HKT |  |
|
Pharmaron recognized with 2 Awards at China Securities Golden Bauhinia Awards Ceremony
Dec 17, 2021 17:45 HKT | |
|
Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100 sites island-wide
Dec 16, 2021 11:00 HKT |  |
|
HMI Group Expands Singapore Presence, Doubles Down on Value-based Care Offering
Dec 10, 2021 13:00 HKT |  |
|
Biolidics to Commence Commercial Production of its ClearEpi SARS-COV-2 Neutralising Antibody Rapid Test Kit
Dec 09, 2021 08:32 HKT |  |
|
Avantor Provides Critical Personal Protection Supplies to Vulnerable Populations through NGOs
Dec 06, 2021 10:00 HKT |  |
|
Acumen Diagnostics' PCR capabilities to tackle Omicron COVID-19 variant
Dec 03, 2021 14:00 HKT |  |
|
SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03
Nov 30, 2021 20:50 HKT | |
|
EC Healthcare Acquires Hong Kong Dental Services Chain
Nov 30, 2021 08:35 HKT | |
|
EC Healthcare Announces FY2021/22 Interim Results
Nov 30, 2021 08:25 HKT | |
|
Jacobson Pharma Announces FY2022 Interim Results
Nov 26, 2021 19:39 HKT |  |
|